Search Results - "Wcislo, Katarzyna"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature by WCISLO, Gabriel, SZARLEJ-WCISLO, Katarzyna, SZCZYLIK, Cezary

    “…There has been only one report available that focuses on the treatment with imatinib mesylate of two individual persons with aggressive fibromatosis. The…”
    Get full text
    Journal Article
  3. 3

    Status of the BRCA1 gene and incidence of hereditary ovarian cancer by Synowiec, Agnieszka, Wcisło, Gabriel, Bodnar, Lubomir, Szarlej-Wcisło, Katarzyna, Cieślak, Agata, Sielużycka, Joanna, Szczylik, Cezary

    Published in Contemporary oncology (Poznań, Poland) (01-04-2010)
    “…Ovarian cancer is the leading cause of mortality in women with gynaecological cancers. Cytoreductive surgery has been considered as a mainstay in manage­ment…”
    Get full text
    Journal Article
  4. 4

    Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients by Synowiec, Agnieszka, Wcisło, Gabriel, Bodnar, Lubomir, Górski, Bohdan, Szenajch, Jolanta, Szarlej-Wcisło, Katarzyna, Szczylik, Cezary

    Published in Hereditary cancer in clinical practice (08-01-2016)
    “…The role of germline mutations in BRCA1 and BRCA2 genes in the risk of the development of ovarian cancer is clinically well established. BRCA1/2 testing seems…”
    Get full text
    Journal Article
  5. 5

    Core content of the medical school surgical curriculum: Consensus report from the association of surgeons in training (ASIT) by Baker, Daniel, Deekonda, Praveena, Mohan, Helen, Srikandarajah, Nisaharan, Walker, Nathan, Brown, Samuel, Peiris, Bryony, Vithlani, Gauri, Webb, Sam, Adams, Niall, Azam, Saima, Bhatia, Sanchita, Bratsos, Paris, Coulson, Rachael, Cunningham, Clare, Curlewis, Keegan, Dawidziuk, Aleksander, Donnelly, Hayley, Jacklin, Chloe, Kenner, Mariam, Khaw, Rachel, Mansell, Leo, McNulty, James, Mills, Emily, Ngadimin, Cleo, Nozdrin, Mikhail, O'Donnell, Matthew, Obiri-Darko, Emma, Pandirajan, Kamashi, Paul, Jeffy, Prentice, James, Smith, Thomas, Szyszka, Bartosz, Valand, Dharmesh, White, Heather, Yoon, Won Young, Ablett, Andrew, Cornwall, Hannah, Evans, Ella, John, Imogen, Kayani, Kayani, Kumar, Hemant, Mak, Richard, Milton, Amelia, Solomou, Georgios, Tincknell, Laura, Zagaran, Alexander, Baker, Daniel, Glasbey, James, Mohan, Helen, Nally, Deirdre, Srikandarajah, Nisaharan, Walker, Nathan, Baker, Daniel, Brown, Samuel, Hughes, Ioan, Tailor, Bhavesh, Vithlani, Gauri, Wcislo, Katarzyna, Webb, Sam, Ahmed, Waheed-Ul-Rahman, Azam, Saima, Choudhry, Hamzah, Coulson, Rachael, Curlewis, Keegan, Hagan, Jonathan, Hughes, Katie, Jacklin, Chloe, Kennett, Jessica, Khaw, Rachel, Madden-McKee, Christopher, Mansell, Leo, Mills, Emily, Mohamed, Tahira, Neo, Wee Xuan, Nozdrin, Mikhail, O'Donnell, Matthew, Pandirajan, Kamashi, Paul, Jeffy, Prentice, James, Pujara, Priyanka, Rubinchik, Polly, Sharp, Elliott, Smith, Thomas, Ta, Ngan Hong, Valand, Dharmesh, White, Heather, Worthington, James, Yoon, Won Young, Cornwall, Hannah, Down, Billy, Evans, Ella, Hoade, Lucy, John, Imogen, Kouli, Omar, Kumar, Hemant, Noor, Muhammed, Onafowokan, Olutusen, Tincknell, Laura, Zagaran, Alexander

    “…The length of time dedicated to the undergraduate surgical curriculum is decreasing. With reduced time on surgical placements, students may be underexposed to…”
    Get full text
    Journal Article
  6. 6

    Salvage therapy with topotecan in heavily pretreated ovarian cancer patients by Bodnar, Lubomir, Wcislo, Gabriel, Nasilowska, Anna, Szarlej-Wcislo, Katarzyna, Gasowska-Bodnar, Agnieszka, Smoter, Marta, Szczylik, Cezary

    “…Background We showed feasibility and efficacy of topotecan in third or a higher line of chemotherapy in heavily pretreated ovarian cancer (HPOC) patients…”
    Get full text
    Journal Article
  7. 7

    Colorectal cancer - adjuvant chemotherapy, and immunotherapy for advanced disease with cetuximab monotherapy, and cancer chemotherapeutic combination by Szczylik, Cezary, Szarlej-Wcislo, Katarzyna, Korniluk, Jan

    Published in Contemporary oncology (Poznań, Poland) (10-08-2005)
    “…Colorectal cancer appears to be a real challenge for modern oncology. The global morbidity and mortality represent 875 K new cases and 570 K deaths per annum,…”
    Get full text
    Journal Article
  8. 8

    Molecular biology of colorectal cancer by Szenajch, Jolanta, Synowiec, Agnieszka, Szarlej-Wcislo, Katarzyna, Cieslak, Agata, Korniluk, Jan, Bodnar, Lubomir

    Published in Contemporary oncology (Poznań, Poland) (15-03-2006)
    “…A human population affected by colorectal cancer embraces residents of the West or others but with their style of life accepted. The global morbidity and…”
    Get full text
    Journal Article
  9. 9

    A novel therapy with zoledronic acid of bone metastasis in advanced prostate cancer reflecting molecular investigations by Oborska, Sylwia, Bodnar, Lubomir, Szarlej-Wcislo, Katarzyna, Szczylik, Cezary

    Published in Contemporary oncology (Poznań, Poland) (01-01-2006)
    “…Prostate cancer continues to represent a major therapeutic challenge. There is still observed a large number of patients worldwide. This malignancy is mainly…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Targeted terapy against angiogenesis in renal cell carcinoma by Pawlak, Wojciech Z, Duchnowska, Renata, Nurzynski, Pawel, Szarlej-Wcislo, Katarzyna, Korniluk, Jan, Wcislo, Gabriel, Obrocka, Beata

    Published in Contemporary oncology (Poznań, Poland) (20-04-2002)
    “…Renal cell carcinoma (RCC) represents 3% of all cancers diagnosed in Poland, and morbidity: 5/100 000, and 2. 8/100000 for male and female, respectively. One…”
    Get full text
    Journal Article
  12. 12

    The role of tumor necrosis factor (TNF-alpha) in therapy of malignant diseases by Nurzynski, Pawel, Szarlej-Wcislo, Katarzyna, Korniluk, Jan, Wcislo, Gabriel, Duchnowska, Renata, Pawlak, Wojciech Z

    Published in Contemporary oncology (Poznań, Poland) (20-04-2002)
    “…Tumor necrosis factor-alpha (TNF-alpha) is a pleiotropic and proinflamatory cytokine with anticancer cytotoxic activity. Although enthusiasm has gone mostly…”
    Get full text
    Journal Article